Catch up on some of the most exciting and impactful developments in science from this year, published on ASN and selected by our editors.
Antibodies active against SARS-CoV-2 found in 20-year-old library
Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.
Delivering CRISPR gene-editing therapy: What’s holding us back?
Genomic editing tools can reverse disease causing mutations to provide cures — once we can conquer the remaining barriers.
How do mutations help SARS-CoV-2 escape our antibodies?
A scientific detective story unearths how SARS-CoV-2 evolves new variants that evade antibodies.
A novel vaccine additive shows good safety profile
A new vaccine adjuvant, which helps stimulate the immune system, has been developed based on two chemicals that are produced by the body.
First human trial of vaccine shows it is safe and induces rapid immune response
Researchers in China give hope for a potential vaccine against SARS-CoV-2.
A universal vaccine could eliminate the need to track evolving strains
An RNA-based vaccine approach that is effective against all virus strains and safe for infants and immunocompromised individuals.
Is there a green path to drug discovery?
Scientists unlock nature’s green secrets to accelerate drug discovery, delivering eco-friendly pharmaceuticals with exciting potential.
Dissolvable microneedles that may ease vaccine hesitancy
Researchers are working to decrease the patient discomfort experienced during vaccination
With fewer disruptive studies, is science becoming an echo chamber?
An analysis of 45 million papers and 3.9 million patents since 1945 shows that the rate of disruptiveness in science is steeply declining.